These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11786486)

  • 1. Assessing the emetic potential of PDE4 inhibitors in rats.
    Robichaud A; Savoie C; Stamatiou PB; Lachance N; Jolicoeur P; Rasori R; Chan CC
    Br J Pharmacol; 2002 Jan; 135(1):113-8. PubMed ID: 11786486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway.
    Robichaud A; Savoie C; Stamatiou PB; Tattersall FD; Chan CC
    Neuropharmacology; 2001; 40(2):262-9. PubMed ID: 11114405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis.
    Robichaud A; Stamatiou PB; Jin SL; Lachance N; MacDonald D; Laliberté F; Liu S; Huang Z; Conti M; Chan CC
    J Clin Invest; 2002 Oct; 110(7):1045-52. PubMed ID: 12370283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats.
    Makhay MM; Houslay MD; O'Donnell JM
    Psychopharmacology (Berl); 2001 Nov; 158(3):297-304. PubMed ID: 11713620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase isoenzyme families in human osteoarthritis chondrocytes--functional importance of phosphodiesterase 4.
    Tenor H; Hedbom E; Häuselmann HJ; Schudt C; Hatzelmann A
    Br J Pharmacol; 2002 Feb; 135(3):609-18. PubMed ID: 11834608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroanatomical and pharmacological assessment of Fos expression induced in the rat brain by the phosphodiesterase-4 inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline.
    Bureau Y; Handa M; Zhu Y; Laliberte F; Moore CS; Liu S; Huang Z; MacDonald D; Xu DG; Robertson GS
    Neuropharmacology; 2006 Oct; 51(5):974-85. PubMed ID: 16901513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases.
    O'Donnell JM; Frith S
    Pharmacol Biochem Behav; 1999 May; 63(1):185-92. PubMed ID: 10340540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo.
    Yamamoto S; Sugahara S; Naito R; Ichikawa A; Ikeda K; Yamada T; Shimizu Y
    Eur J Pharmacol; 2006 Jul; 541(1-2):106-14. PubMed ID: 16780833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1-5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia.
    Yu MC; Chen JH; Lai CY; Han CY; Ko WC
    Eur J Pharmacol; 2010 Feb; 627(1-3):269-75. PubMed ID: 19853596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feeding in rats as a measure of emetogenicity.
    Davis TG; Peterson JJ; Kou JP; Capper-Spudich EA; Ball D; Nials AT; Wiseman J; Solanke YE; Lucas FS; Williamson RA; Ferrari L; Wren P; Knowles RG; Barnette MS; Podolin PL
    J Pharmacol Exp Ther; 2009 Sep; 330(3):922-31. PubMed ID: 19498103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
    Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture.
    Miyamoto K; Suzuki H; Yamamoto S; Saitoh Y; Ochiai E; Moritani S; Yokogawa K; Waki Y; Kasugai S; Sawanishi H; Yamagami H
    J Bone Miner Res; 2003 Aug; 18(8):1471-7. PubMed ID: 12929936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor.
    Macdonald D; Mastracchio A; Perrier H; Dubé D; Gallant M; Lacombe P; Deschênes D; Roy B; Scheigetz J; Bateman K; Li C; Trimble LA; Day S; Chauret N; Nicoll-Griffith DA; Silva JM; Huang Z; Laliberté F; Liu S; Ethier D; Pon D; Muise E; Boulet L; Chan CC; Styhler A; Charleson S; Mancini J; Masson P; Claveau D; Nicholson D; Turner M; Young RN; Girard Y
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5241-6. PubMed ID: 16168647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha adrenoceptor subtypes involved in the emetic action in dogs.
    Hikasa Y; Ogasawara S; Takase K
    J Pharmacol Exp Ther; 1992 May; 261(2):746-54. PubMed ID: 1349647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single inhibition of either PDE3 or PDE4 unmasks β2-adrenoceptor-mediated inotropic and lusitropic effects in the left but not right ventricular myocardium of rat.
    Soler F; Fernández-Belda F; Pérez-Schindler J; Hernández-Cascales J
    Eur J Pharmacol; 2015 Oct; 765():429-36. PubMed ID: 26364538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site.
    Martin C; Göggel R; Dal Piaz V; Vergelli C; Giovannoni P; Ernst M; Uhlig S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):284-9. PubMed ID: 11919652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.